Our investigation is consistent with a prior report showing that ABR-215757 reduced diabetes-accelerated atherosclerosis in STZ-treated ApoE−/− mice, associated with reduced macrophage and lipid content17. This evidence concerns the gene APOE and atherosclerosis.